Physician profile
Christopher C Edwards
NPI 1821307877
$12,262.47
in general payments reported to CMS, 2019-2025
54 companies · $954 in 2025
The $954 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,790 · 2020: $1,202 · 2021: $1,231 · 2022: $1,913 · 2023: $949 · 2024: $4,224 · 2025: $954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,627 · Consulting Fee: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,627.10 |
| Consulting Fee | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $3,778.88 | 2021-2025 | Venclose Maven Catheter, Crosser Iq |
| Janssen Pharmaceuticals, INC | $1,084.86 | 2019-2024 | Xarelto |
| Abbott Laboratories | $947.42 | 2019-2022 | |
| Boston Scientific Corporation | $936.03 | 2019-2025 | Watchman Flx, General - Vascular Intervention, Varithena Administration Pack |
| Medtronic, INC. | $606.41 | 2021-2024 | Linq II, Abre, Symplicity G3 |
| Merck Sharp & Dohme LLC | $448.81 | 2021-2025 | Verquvo |
| Avinger INC. | $388.53 | 2019-2022 | |
| Pfizer INC. | $317.60 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $285.52 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $279.19 | 2019-2025 | Camzyos |
| Canon Medical Systems USA, INC. | $273.22 | 2022 | |
| Venclose INC. | $231.79 | 2020 | |
| Opsens INC. | $227.54 | 2019 | |
| Medtronic Vascular, INC. | $212.56 | 2019-2020 | |
| Cvrx, INC. | $209.35 | 2022-2025 | Barostim Neo System |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.